Dr. Chandar Thakur, chief of the Medical Devices and Diagnostics Branch at DHA R&D-MRDC’s Office of Regulated Activities, is the 2024 Employee of the Year.

The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to multiple reports.

The FDA has approved a new at-home test for common sexually transmitted infections and diseases. The test for chlamydia, ...

Vivex Biologics chairman John McCallum breaks down the challenges, costs, and strategies behind bringing medical innovations ...

The U.S. Food and Drug Administration has approved expanded use of Amgen's drug, Uplizna, to help reduce the risk of flares ...

Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who ...

The Food and Drug Administration (FDA) has granted accelerated approval to Vanrafia ® (atrasentan) to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

The U.S. Supreme Court upheld a series of decisions on Thursday by the US Food and Drug Administration to keep flavored ...

The Supreme Court on Wednesday ruled for the FDA in its crackdown on sweet-flavored vaping products following a surge in teen ...

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...